Tech Company Financing Transactions
Advanced NanoTherapies Funding Round
S3 Ventures and private investors participated in a $31 million Series B funding round for Advanced NanoTherapies. The funding round closed on 6/2/2026.
Transaction Overview
Company Name
Announced On
6/2/2026
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Series B
Investors
S3 Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to scale up its manufacturing capabilities, secure U.S. Investigational Device Exemption (IDE) approvals, advance its coronary clinical trials, and expand into below-the-knee peripheral applications.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Undisclosed
Mountain View, CA 95039
USA
Mountain View, CA 95039
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marwan Berrada-Sounni
VP - R & D
Frank Proch
Browse more venture capital transactions:
Prev: 6/2/2026: SewerAI venture capital transaction
Next: 6/2/2026: Mafer AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs